Literature DB >> 11120993

Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile.

E L Palavecino1, I Riedel, X Berrios, S Bajaksouzian, D Johnson, E Kaplan, M R Jacobs.   

Abstract

Thirty-two macrolide-resistant Streptococcus pyogenes isolates were found among 594 clinical isolates collected from 1990 to 1998 in Santiago, Chile, for an overall prevalence of 7.2%. Among the 32 resistant isolates, 28 (87.5%) presented the M phenotype and 4 (12. 5%) presented the MLS(B) phenotype. Serotyping and pulsed-field gel electrophoresis analysis showed genetic diversity among the resistant isolates.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11120993      PMCID: PMC90288          DOI: 10.1128/AAC.45.1.339-341.2001

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997.

Authors:  E L Kaplan; D R Johnson; M C Del Rosario; D L Horn
Journal:  Pediatr Infect Dis J       Date:  1999-12       Impact factor: 2.129

2.  Resistance to erythromycin in group A streptococci.

Authors:  H Seppälä; A Nissinen; H Järvinen; S Huovinen; T Henriksson; E Herva; S E Holm; M Jahkola; M L Katila; T Klaukka
Journal:  N Engl J Med       Date:  1992-01-30       Impact factor: 91.245

3.  Erythromycin resistance genes in group A streptococci in Finland. The Finnish Study Group for Antimicrobial Resistance.

Authors:  J Kataja; P Huovinen; M Skurnik; H Seppälä
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

4.  Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: results of a 1-year (1996-1997) multicenter surveillance study. The Spanish Surveillance Group for Respiratory Pathogens.

Authors:  F Baquero; J A García-Rodríguez; J G de Lomas; L Aguilar
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

5.  Variation in erythromycin and clindamycin susceptibilities of Streptococcus pneumoniae by four test methods.

Authors:  E L Fasola; S Bajaksouzian; P C Appelbaum; M R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland.

Authors:  H Seppälä; A Nissinen; Q Yu; P Huovinen
Journal:  J Antimicrob Chemother       Date:  1993-12       Impact factor: 5.790

7.  Susceptibility of 1100 Streptococcus pneumoniae strains isolated in 1997 from seven Latin American and Caribbean countries. Laser Study Group.

Authors:  M R Jacobs; P C Appelbaum
Journal:  Int J Antimicrob Agents       Date:  2000-09       Impact factor: 5.283

8.  Emergence of Streptococcus pyogenes strains resistant to erythromycin in Gipuzkoa, Spain.

Authors:  E Perez-Trallero; M Urbieta; M Montes; I Ayestaran; J M Marimon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-01       Impact factor: 3.267

9.  Detection of erythromycin-resistant determinants by PCR.

Authors:  J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

10.  Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system.

Authors:  J Sutcliffe; A Tait-Kamradt; L Wondrack
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

View more
  6 in total

1.  Mechanisms of macrolide resistance in clinical group B streptococci isolated in France.

Authors:  F Fitoussi; C Loukil; I Gros; O Clermont; P Mariani; S Bonacorsi; I Le Thomas; D Deforche; E Bingen
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy.

Authors:  Giordano Dicuonzo; Ersilia Fiscarelli; Giovanni Gherardi; Giulia Lorino; Fabrizio Battistoni; Simona Landi; Marina De Cesaris; Tommasangelo Petitti; Bernard Beall
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

3.  Erythromycin-resistant group a streptococcal isolates collected between 2000 and 2005 in Oahu, Hawaii, and their emm types.

Authors:  Guliz Erdem; Jacqueline Ford; Dwight Johnson; Lucienne Abe; Karen Yamaga; Edward Kaplan
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Reemergence of macrolide resistance in pharyngeal isolates of group a streptococci in southwestern Pennsylvania.

Authors:  Michael Green; Judith M Martin; Karen A Barbadora; Bernard Beall; Ellen R Wald
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

5.  Resistance determinants and clonal diversity in group A streptococci collected during a period of increasing macrolide resistance.

Authors:  Stefania Cresti; Maria Lattanzi; Alessandra Zanchi; Francesca Montagnani; Simona Pollini; Carla Cellesi; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

6.  Contribution of exogenous genetic elements to the group A Streptococcus metagenome.

Authors:  Stephen B Beres; James M Musser
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.